Abstract
Metastasis, the dissemination and growth of neoplastic cells in an organ distinct from that in which they originated1,2, is the most common cause of death in cancer patients. This is particularly true for pancreatic cancers, where most patients are diagnosed with metastatic disease and few show a sustained response to chemotherapy or radiation therapy3. Whether the dismal prognosis of patients with pancreatic cancer compared to patients with other types of cancer is a result of late diagnosis or early dissemination of disease to distant organs is not known. Here we rely on data generated by sequencing the genomes of seven pancreatic cancer metastases to evaluate the clonal relationships among primary and metastatic cancers. We find that clonal populations that give rise to distant metastases are represented within the primary carcinoma, but these clones are genetically evolved from the original parental, non-metastatic clone. Thus, genetic heterogeneity of metastases reflects that within the primary carcinoma. A quantitative analysis of the timing of the genetic evolution of pancreatic cancer was performed, indicating at least a decade between the occurrence of the initiating mutation and the birth of the parental, non-metastatic founder cell. At least five more years are required for the acquisition of metastatic ability and patients die an average of two years thereafter. These data provide novel insights into the genetic features underlying pancreatic cancer progression and define a broad time window of opportunity for early detection to prevent deaths from metastatic disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Fidler, I. J. Critical determinants of metastasis. Semin. Cancer Biol. 12, 89–96 (2002)
Nguyen, D. X., Bos, P. D. & Massague, J. Metastasis: from dissemination to organ-specific colonization. Nature Rev. Cancer 9, 274–284 (2009)
Stathis, A. & Moore, M. J. Advanced pancreatic carcinoma: current treatment and future challenges. Nature Rev. Clin. Oncol. 7, 163–172 (2010)
Yachida, S. & Iacobuzio-Donahue, C. A. The pathology and genetics of metastatic pancreatic cancer. Arch. Pathol. Lab. Med. 133, 413–422 (2009)
Jones, S. et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321, 1801–1806 (2008)
Maitra, A. & Hruban, R. H. pancreatic cancer. Annu. Rev. Pathol. 3, 157–188 (2008)
Lengauer, C., Kinzler, K. W. & Vogelstein, B. Genetic instabilities in human cancers. Nature 396, 643–649 (1998)
Jones, S. et al. Comparative lesion sequencing provides insights into tumor evolution. Proc. Natl Acad. Sci. USA 105, 4283–4288 (2008)
Terada, T. et al. Cell proliferative activity in intraductal papillary-mucinous neoplasms and invasive ductal adenocarcinomas of the pancreas: an immunohistochemical study. Arch. Pathol. Lab. Med. 122, 42–46 (1998)
Hisa, T. et al. Growth process of small pancreatic carcinoma: a case report with imaging observation for 22 months. World J. Gastroenterol. 14, 1958–1960 (2008)
Olive, K. P. et al. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 324, 1457–1461 (2009)
Sidransky, D. Emerging molecular markers of cancer. Nature Rev. Cancer 2, 210–219 (2002)
Embuscado, E. E. et al. Immortalizing the complexity of cancer metastasis: genetic features of lethal metastatic pancreatic cancer obtained from rapid autopsy. Cancer Biol. Ther. 4, 548–554 (2005)
Fu, B. et al. Evaluation of GATA-4 and GATA-5 methylation profiles in human pancreatic cancers indicate promoter methylation patterns distinct from other human tumor types. Cancer Biol. Ther. 6, 1546–1552 (2007)
Peiffer, D. A. et al. High-resolution genomic profiling of chromosomal aberrations using Infinium whole-genome genotyping. Genome Res. 16, 1136–1148 (2006)
Bignell, G. R. et al. Signatures of mutation and selection in the cancer genome. Nature 463, 893–898 (2010)
Sasaki, K. et al. Relationship between labeling indices of KI-67 and brdurd in human malignant tumors. Cancer 62, 989–993 (1988)
Rew, D. A. & Wilson, G. D. Cell production rates in human tissues and tumours and their significance. Part II: clinical data. Eur. J. Surg. Oncol. 26, 405–417 (2000)
Steel, G. G. The Growth Kinetics of Tumours. (Clarendon Press, Oxford, 1977)
Amikura, K., Kobari, M. & Matsuno, S. The time of occurrence of liver metastasis in carcinoma of the pancreas. Int. J. Pancreatol. 17, 139–146 (1995)
Naumov, G. N. et al. A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype. J. Natl. Cancer Inst. 98, 316–325 (2006)
Acknowledgements
This work was supported by National Institutes of Health grants CA106610 (C.A.I.-D.), CA62924 (C.A.I.-D., M.A.N.), CA43460 (B.V.), CA57345 (K.W.K. and V.E.V.), CA121113 (V.E.V. and K.W.K.), GM078986 (M.A.N.), the Bill and Melinda Gates Foundation Grand Challenges Grant 37874, the Uehara Memorial Foundation (S.Y.), the AACR-Barletta Foundation (C.A.I.-D.), the John Templeton Foundation, Pilot Funding from the Sol Goldman Pancreatic Cancer Research Center, the Michael Rolfe Pancreatic Cancer Foundation, the George Rubis Endowment for Pancreatic Cancer Research, the Joseph C. Monastra Foundation for Pancreatic Cancer Research, the Alfredo Scatena Memorial Fund, the Virginia and the D.K. Ludwig Fund for Cancer Research, The Joint Program in Mathematical Biology and J. Epstein. We would like to acknowledge T. C. Cornish, C. Henderson, N. Omura and S.-M. Hong for their technical assistance in selected aspects of this work.
Author information
Authors and Affiliations
Contributions
Sample collection and processing was performed by C.A.I.-D., S.Y., B.F. and M.K. Microdissection, DNA extractions and whole genome amplification reactions were performed by S.Y. Sequencing was performed by S.J. Copy number analyses were performed by R.L. Computational models and estimates of clonal evolution were performed by I.B., T.A. and M.A.N.; C.A.I.-D., S.Y., S.J., R.H.H., J.R.E., M.A.N., I.B., T.A., V.E.V., K.W.K. and B.V. directed the research. C.A.I.-D., B.V., S.Y., I.B. and T.A. wrote the manuscript, which all authors have approved.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Information
This file contains a Supplementary Discussion, additional references, Supplementary Figures 1-8 with legends and Supplementary Tables 1-6. (PDF 679 kb)
Rights and permissions
About this article
Cite this article
Yachida, S., Jones, S., Bozic, I. et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467, 1114–1117 (2010). https://doi.org/10.1038/nature09515
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature09515
This article is cited by
-
Simulating the healthcare workforce impact and capacity for pancreatic cancer care in Victoria: a model-based analysis
BMC Health Services Research (2024)
-
Postbiotic butyrate: role and its effects for being a potential drug and biomarker to pancreatic cancer
Archives of Microbiology (2024)
-
Genetic and other risk factors for pancreatic ductal adenocarcinoma (PDAC)
Familial Cancer (2024)
-
CT041 CAR T cell therapy for Claudin18.2-positive metastatic pancreatic cancer
Journal of Hematology & Oncology (2023)
-
Liquid biopsy techniques and pancreatic cancer: diagnosis, monitoring, and evaluation
Molecular Cancer (2023)